Tourmaline Bio’s Post

📢 ProDigest is attending this year’s Bridge2Food Europe summit in the Hague! 🔗 Connect with Massimo Marzorati to learn more about our gastrointestinal research capabilities! 🔍 𝐖𝐡𝐨 𝐚𝐫𝐞 𝐰𝐞? We are the leading experts in #preclinical food, feed and drug gastrointestinal research, by utilizing our 𝐛𝐞𝐬𝐭-𝐢𝐧-𝐜𝐥𝐚𝐬𝐬 𝒊𝒏 𝒗𝒊𝒕𝒓𝒐 and 𝒆𝒙 𝒗𝒊𝒗𝒐 𝐠𝐚𝐬𝐭𝐫𝐨𝐢𝐧𝐭𝐞𝐬𝐭𝐢𝐧𝐚𝐥 𝐬𝐢𝐦𝐮𝐥𝐚𝐭𝐢𝐨𝐧𝐬 🌱 🔬 𝐖𝐡𝐚𝐭 𝐭𝐨 𝐞𝐱𝐩𝐞𝐜𝐭 𝐟𝐫𝐨𝐦 𝐏𝐫𝐨𝐃𝐢𝐠𝐞𝐬𝐭? •𝐏𝐫𝐞𝐜𝐢𝐬𝐢𝐨𝐧 𝐬𝐢𝐦𝐮𝐥𝐚𝐭𝐢𝐨𝐧𝐬: Mimicking human digestion for game-changing insights that serve as a #derisk strategy for #ClinicalTrials ✨ •𝐏𝐫𝐨𝐯𝐞𝐧 𝐞𝐱𝐩𝐞𝐫𝐭𝐢𝐬𝐞 from early phases to product development •𝐓𝐚𝐢𝐥𝐨𝐫-𝐦𝐚𝐝𝐞 𝐬𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬 for diverse conditions See you at the summit! 🥂 #Microbiome #GutHealth #Innovation #AlternativeProteins #NovelFood #PlantBased #PlantBasedFood #PlantBasedProtein #Sustainability #SustainableFood #ProteinFermentation

The Smart Monkeys: An Animal Experiment FAIL Story! A team of research scientists had selected four groups of monkeys for a pharmaceutical experiment. The animals in the first group were to receive a high dose of the drug being studied. Those in the second group were to get a moderate dose. The monkeys in the third group were scheduled to receive a low dose of the drug. And those in the fourth group were to be injected with a placebo. The day before the experiment was to begin, the monkeys in the high-dose group were deprived of food while those in the other three groups were fed as usual. On the morning of the experiment, tests revealed unexpected nutrients in the blood of the fasting monkeys. The researchers were surprised. They decided to repeat the previous day’s procedure, but this time they were going to observe the behavior of the monkeys at night when the lights were off. The researchers made a touching discovery. The monkeys who were being fed were passing their food to their hungry friends who were being deprived of food. Key Business Lessons one can learn from the above story: #1. Collaboration and Empathy: The story highlights the power of collaboration and empathy among the monkeys. In business, fostering a culture where team members support and empathize with each other can lead to a more harmonious and productive work environment. #CollaborationCulture #2. Unexpected Insights: The researchers gained unexpected insights when they observed the monkeys in different conditions. Similarly, in business, being open to unexpected outcomes and insights can lead to innovative solutions and opportunities. #EmbraceUnexpected #3. Community Over Self: The monkeys chose to share their food with those in need, prioritizing the community over individual needs. In business, promoting a mindset that values the success of the team and the organization over individual achievements can contribute to a stronger and more resilient workplace. #CommunityOverSelf Actions for Business Owners: #1. Foster Team Collaboration: Encourage collaboration and teamwork within your organization. Create opportunities for employees to support each other and work together towards common goals. #TeamCollaboration #2. Encourage Open-Mindedness: Cultivate a culture where unexpected findings and unconventional ideas are welcomed. Encourage employees to explore new approaches and be open to unforeseen insights that may lead to business improvement. #OpenMindedCulture #3. Promote a Community Mindset: Instill a sense of community within your team. Acknowledge and reward behaviors that demonstrate a commitment to the collective success of the organization. #CommunityMindset What do you do in your business to promote Team Collaboration, Open-minded Culture, and a Community Mindset? Share your views! Have a wonderful Wednesday!

Good opportunity to learn from SciBite’s Head of Ontologies, Jane Lomax, and J Christian Baber from Pistoia Alliance on the importance and application of #ontologies in the context of #genAI in the #lifesciences.

VINS Bio participated in the 'First National Conference on Recent Advances and Challenges in Hyperimmune Sera Production,' held from September 8th to 10th at the Central Research Institute, Kasauli. The event focused on critical themes such as advancements in hyperimmune sera production, regulatory and quality standards, adjuvants, and innovations in immunoprophylactic and therapeutics. Prof. (Dr.) Atul Goel, Directorate General Of Health Services, graced the event as Chief Guest, alongside Dr. Dimple Kasana, Director of Central Research Institute as Chief Patron. Commenting on the conference, Siddharth Daga, Chief Executive Officer, VINS Bioproducts Limited highlighted how VINS Bio leads the market in equine antisera production, and how valuable discussions on advancements and challenges in this field were. These exchanges not only provide insights but also shape how we manage and navigate emerging hurdles. We look forward to more such enriching experiences in the future! #VINSBio #HyperimmuneSera #Immunotherapy #ConferenceNetworking #LifelongLearning

News Release - BioHarvest Sciences Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program. Read full release: www.bioharvest.com/news. Quote from CEO Ilan Sobel: “We have removed all barriers for botanical compositions to become reliable, consistent, and economically viable sources for the next generation of science based therapeutic solutions, which have the ability to impact hundreds of millions of consumers whose health and wellness needs are being underserved by existing technologies. Today, we stand in a stronger position than ever to deliver shareholder value by leveraging our proven botanical synthesis platform. Consistent delivery of both quarter-on-quarter revenue and margin improvement has earned BioHarvest the performance credibility to now actively engage with retail, family office and institutional investors. We look forward to partnering with MZ Group to showcase our distinct biotech capabilities to a much broader network of growth-oriented investors.”

Get expert advice on how to get reliable #immunoassay results in this upcoming Bitesize Bio webinar.

If you are developing a therapeutic, this session is for you to find out what national infrastructure and support exists that you can tap into.

The Vitrolife Group interim report Q1, 2024 has been released today. “We continue to make progress on the execution of our corporate strategy which is our blueprint to return the Vitrolife Group to double digit growth in the long term” -Bronwyn Brophy, CEO Vitrolife Group Read the report: https://ow.ly/Wihx50RiJOH #VitrolifeGroup #Vitrolife #Igenomix #Interimreport

Are you planning a clinical or preclinical study for your next innovation? Over the last 22 years, we've helped a large number of companies develop award-winning probiotics, postbiotics, prebiotics and even synbiotics through clinical trials! Jayesh Chaudhary and Anuj Chipkar will be at #Probiota in #Milan this week. Grab this opportunity to ask them questions about our latest experiences and new offerings. #probiotics #tradeshow #europe #clinicalresearch #clinicaltrials

The Latest BHI Weekly E-Newsletter is live with: 🌍 Revolutionizing Drug Manufacturing: Dr. Frank Gupton or Phlow and Medicines for All Institute discusses innovations in pharmaceutical production and access to essential medications on the BioTalk Podcast 🗓️ TEDCO's BioHealth Capital Region Forum Recap: The event highlighted trends and collaborations within the life sciences industry, marking a decade of impact. - Tammi Thomas 🧠 BrainScope Completes #Alzheimer’s Biomarker Study: The company announces successful proof-of-concept for a novel early prediction biomarker. 📈 Cartesian Therapeutics Presents Phase 2b Trial Data: Results from a trial on Descartes-08 for myasthenia gravis were shared at a significant scientific session. 🏥 US Pharmacopeia Acquires Stratix Labs Corporation (a USP company): The acquisition enhances microbiological solutions to support pharmaceutical quality control. 💉 Seraxis Receives FDA IND Allowance: The company is set to begin a clinical study of its novel islet replacement therapy for type 1 diabetes. 🤝 MacroGenics, Inc. and TerSera Therapeutics Partner: The agreement involves the sale of global rights to MARGENZA® (margetuximab-cmkb). 👁️ REGENXBIO Shares Phase II Data: The company presents positive results on a treatment for wet age-related macular degeneration at a major meeting. 🧪 Supernus Pharmaceuticals, Inc. Announces Positive Phase 2a Results: The study of SPN-820 in adults with major depressive disorder shows promising outcomes. 🏗️ University Partnerships Foster Innovation: A new development in Albemarle County, VA aims to enhance collaboration between academia and industry. 💰 Pediatric Medical Device Competition Winners Announced: Six innovators receive grants to advance solutions for pediatric cardiology. 📈 Maryland MedTech Ecosystem Features: Unique resources and infrastructure support innovation in medical technology, according to a recent analysis. 🌟 SPARK Accelerator Focuses on Pediatric MCMs: The initiative aims to enhance medical countermeasures for children in public health emergencies. 📊 BIO Investor Forum Highlights Financing Trends: The event underscores a rise in biotech investment, though disparities persist among small companies. https://lnkd.in/gxZunjFq